+19.8%
BIL vs GSK
+44.6%
-24.7%
-0.3%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 5y.
| Period | Portfolio | GSK | Excess | Alpha |
|---|---|---|---|---|
| 1D | 0.0% | -0.6% | +0.6% | 0.0% |
| 7D | +0.1% | +5.2% | -5.1% | +0.1% |
| 30D | 0.0% | +10.2% | -10.2% | 0.0% |
| 3M | +0.6% | -0.9% | +1.5% | +0.6% |
| 6M | +1.5% | +3.5% | -2.0% | +1.5% |
| YTD | +2.8% | +7.2% | -4.4% | +2.8% |
| 1Y | +3.3% | +12.0% | -8.7% | +3.3% |
| 3Y | +13.4% | +67.3% | -53.9% | +13.4% |
| 5Y | +19.8% | +45.3% | -25.4% | +19.8% |
| All | +19.8% | +44.6% | -24.7% | +19.8% |
Cumulative growth
Daily Returns
Daily percentage return beside GSK.
Daily Out/Under-Performance
Portfolio return minus GSK return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 5y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
5y analysis · Full analysis span regression · 6 months rolling